634 related articles for article (PubMed ID: 11899578)
1. [Atrial fibrillation: always cardioversion? No].
Di Pasquale G; Biancoli S; Sassone B; Pancaldi LG
Ital Heart J Suppl; 2002 Jan; 3(1):81-90. PubMed ID: 11899578
[TBL] [Abstract][Full Text] [Related]
2. Atrial fibrillation: rate control often better than rhythm control.
Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
[TBL] [Abstract][Full Text] [Related]
3. Rhythm control versus rate control in patients with persistent atrial fibrillation. Results of the HOT CAFE Polish Study.
Opolski G; Torbicki A; Kosior D; Szulc M; Zawadzka M; Pierścińska M; Kołodziej P; Stopiński M; Wozakowska-Kapłon B; Achremczyk P; Rabczenko D
Kardiol Pol; 2003 Jul; 59(7):1-16; discussion 15-16. PubMed ID: 14560344
[TBL] [Abstract][Full Text] [Related]
4. Effects of sinus rhythm restoration in patients with persistent atrial fibrillation: a clinical, echocardiographic and hormonal study.
Wozakowska-Kapłon B; Opolski G
Int J Cardiol; 2004 Aug; 96(2):171-6. PubMed ID: 15262030
[TBL] [Abstract][Full Text] [Related]
5. Targeted pharmacological reversal of electrical remodeling after cardioversion--rationale and design of the Flecainide Short-Long (Flec-SL) trial.
Kirchhof P; Fetsch T; Hanrath P; Meinertz T; Steinbeck G; Lehmacher W; Breithardt G
Am Heart J; 2005 Nov; 150(5):899. PubMed ID: 16290956
[TBL] [Abstract][Full Text] [Related]
6. Impact of sinus rhythm restoration and maintenance on left ventricular function and exercise tolerance in patients with persistent atrial fibrillation.
Kosior DA; Stawicki S; Wozakowska-Kapłon B; Szulc M; Opolski G; Rabczenko D
Kardiol Pol; 2005 Jul; 63(7):36-47; discussion 48-9. PubMed ID: 16136427
[TBL] [Abstract][Full Text] [Related]
7. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome.
Boriani G; Diemberger I; Biffi M; Domenichini G; Martignani C; Valzania C; Branzi A
Int J Clin Pract; 2007 May; 61(5):748-56. PubMed ID: 17493088
[TBL] [Abstract][Full Text] [Related]
8. Management of persistent atrial fibrillation following balloon mitral valvotomy: safety and efficacy of low-dose amiodarone.
Kapoor A; Kumar S; Singh RK; Pandey CM; Sinha N
J Heart Valve Dis; 2002 Nov; 11(6):802-9. PubMed ID: 12479281
[TBL] [Abstract][Full Text] [Related]
9. Management of atrial fibrillation.
Hersi A; Wyse DG
Curr Probl Cardiol; 2005 Apr; 30(4):175-233. PubMed ID: 15778690
[TBL] [Abstract][Full Text] [Related]
10. Prediction of maintenance of sinus rhythm after electrical cardioversion of atrial fibrillation by non-deterministic modelling.
Zohar P; Kovacic M; Brezocnik M; Podbregar M
Europace; 2005 Sep; 7(5):500-7. PubMed ID: 16087117
[TBL] [Abstract][Full Text] [Related]
11. AFFIRM and RACE trials: implications for the management of atrial fibrillation.
Blackshear JL; Safford RE; ;
Card Electrophysiol Rev; 2003 Dec; 7(4):366-9. PubMed ID: 15071255
[TBL] [Abstract][Full Text] [Related]
12. Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods.
Naegeli B; Straumann E; Bertel O
Int J Cardiol; 2005 Mar; 99(2):283-7. PubMed ID: 15749188
[TBL] [Abstract][Full Text] [Related]
13. Effect of atrial fibrillation duration on probability of immediate recurrence after transthoracic cardioversion.
Oral H; Ozaydin M; Sticherling C; Tada H; Scharf C; Chugh A; Lai SW; Pelosi F; Knight BP; Strickberger SA; Morady F
J Cardiovasc Electrophysiol; 2003 Feb; 14(2):182-5. PubMed ID: 12693502
[TBL] [Abstract][Full Text] [Related]
14. Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study.
Lee JK; Klein GJ; Krahn AD; Yee R; Zarnke K; Simpson C; Skanes A; Spindler B
Am Heart J; 2000 Dec; 140(6):871-7. PubMed ID: 11099990
[TBL] [Abstract][Full Text] [Related]
15. Management of atrial fibrillation in the elderly.
Aronow WS
Minerva Med; 2009 Feb; 100(1):3-24. PubMed ID: 19182738
[TBL] [Abstract][Full Text] [Related]
16. Improvement in exercise performance after successful cardioversion in patients with persistent atrial fibrillation and symptoms of heart failure.
Wozakowska-Kapłon B; Opolski G
Kardiol Pol; 2003 Sep; 59(9):213-23. PubMed ID: 14618198
[TBL] [Abstract][Full Text] [Related]
17. Cardioversion of atrial fibrillation: the use of antiarrhythmic drugs.
Schilling RJ
Heart; 2010 Mar; 96(5):333-8. PubMed ID: 19910286
[TBL] [Abstract][Full Text] [Related]
18. [Atrial defibrillator].
Jung W; Lüderitz B
Z Kardiol; 2000; 89 Suppl 3():206-14. PubMed ID: 10810804
[TBL] [Abstract][Full Text] [Related]
19. [Epidemiology and therapy of atrial fibrillation].
Capucci A; Aschieri D; Villani GQ
Ann Ital Med Int; 1996 Oct; 11 Suppl 2():5S-10S. PubMed ID: 9004821
[TBL] [Abstract][Full Text] [Related]
20. Low-energy internal cardioversion in patients with long-lasting atrial fibrillation refractory to external electrical cardioversion: results and long-term follow-up.
Gasparini G; Bonso A; Themistoclakis S; Giada F; Raviele A
Europace; 2001 Apr; 3(2):90-5. PubMed ID: 11333060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
